172 related articles for article (PubMed ID: 5546195)
21. Reactivation of dihydrofolate reductase inhibted by methotrexate or aminopterin.
Jackson RC; Niethammer D; Hart LI
Arch Biochem Biophys; 1977 Aug; 182(2):646-56. PubMed ID: 561567
[No Abstract] [Full Text] [Related]
22. Immunologic heterogeneity of dihydrofolate reductase from methotrexate sensitive and resistant L1210 leukemia cells.
Iqbal MP; Rothenberg SP; Larosa C
Proc Soc Exp Biol Med; 1985 Oct; 180(1):98-102. PubMed ID: 2412235
[TBL] [Abstract][Full Text] [Related]
23. S-phase cells of rapidly growing and resting populations. Differences in response to methotrexate.
Hryniuk WM; Fischer GA; Bertino JR
Mol Pharmacol; 1969 Nov; 5(6):557-64. PubMed ID: 5392913
[No Abstract] [Full Text] [Related]
24. The use of dihydrofolate reductase as a signal for scheduling optimal treatment with antileukemic agents.
Hardesty CT; Chen D; Mead JA
Cancer Res; 1972 Mar; 32(3):458-61. PubMed ID: 5061301
[No Abstract] [Full Text] [Related]
25. Dihydrofolate reductase activity of leukemia L1210 during development of methotrexate resistance.
Schrecker AW; Mead JA; Greenberg NH; Goldin A
Biochem Pharmacol; 1971 Mar; 20(3):716-8. PubMed ID: 5150168
[No Abstract] [Full Text] [Related]
26. A new fluorescent dihydrofolate reductase probe for studies of methotrexate resistance.
Rosowsky A; Wright JE; Shapiro H; Beardsley P; Lazarus H
J Biol Chem; 1982 Dec; 257(23):14162-7. PubMed ID: 7142200
[TBL] [Abstract][Full Text] [Related]
27. "Induction" of dihydrofolate reductase: purification and properties of the "induced" human erythrocyte and leukocyte enzyme and normal bone marrow enzyme.
Bertino JR; Cashmore AR; Hillcoat BL
Cancer Res; 1970 Sep; 30(9):2372-8. PubMed ID: 4394460
[No Abstract] [Full Text] [Related]
28. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.
Mauritz R; Peters GJ; Kathmann I; Teshale H; Noordhuis P; Comijn EM; Pinedo HM; Jansen G
Cancer Chemother Pharmacol; 2008 Nov; 62(6):937-48. PubMed ID: 18283461
[TBL] [Abstract][Full Text] [Related]
29. Dialkyl esters of methotrexate and 3',5'-dichloromethotrexate: synthesis and interaction with aldehyde oxidase and dihydrofolate reductase.
Johns DG; Farquhar D; Wolpert MK; Chabner BA; Loo TL
Drug Metab Dispos; 1973; 1(3):580-9. PubMed ID: 4149453
[No Abstract] [Full Text] [Related]
30. Identification of a high-molecular-weight nonfunctional protein in L1210 leukemia cells with common antigenic determinants to dihydrofolate reductase.
Rothenberg SP; Iqbal MP
Cancer Res; 1983 Feb; 43(2):529-35. PubMed ID: 6184148
[TBL] [Abstract][Full Text] [Related]
31. Analogues of folate antagonists as affinity and fluorescent probes of dihydrofolate reductase structure and function.
Freisheim JH; Price EM; Kumar AA; Susten SS; Smith PL; Delcamp TJ
Biochem Soc Trans; 1986 Apr; 14(2):371-3. PubMed ID: 3086153
[No Abstract] [Full Text] [Related]
32. Drug response, dihydrofolate reductase, and cytogenetics of amethopterin-resistant Chinese hamster cells in vitro.
Biedler JL; Albrecht AM; Hutchison DJ; Spengler BA
Cancer Res; 1972 Jan; 32(1):153-61. PubMed ID: 5007683
[No Abstract] [Full Text] [Related]
33. A nonfunctional protein in human leukemia cells reacts with antiserum to dihydrofolate reductase from L1210 leukemia cells.
Iqbal MP; Rothenberg SP
Life Sci; 1981 Aug; 29(7):689-96. PubMed ID: 6168882
[No Abstract] [Full Text] [Related]
34. Multiple forms of L1210 dihydrofolate reductase differing in affinity for methotrexate.
Duffy TH; Beckman SB; Huennekens FM
Biochem Biophys Res Commun; 1984 Feb; 119(1):352-8. PubMed ID: 6704125
[TBL] [Abstract][Full Text] [Related]
35. Polymorphism of dihydrofolate reductase from a methotrexate-resistant subline of L1210 cells.
Duffy TH; Beckman SB; Sato JK; Nagae H; Vitols KS; Huennekens FM
Adv Enzyme Regul; 1985; 23():3-12. PubMed ID: 4072799
[TBL] [Abstract][Full Text] [Related]
36. Effect of methotrexate on dihydrofolate reductase activity in methotrexate-resistant human KB cells.
Domin BA; Grill SP; Bastow KF; Cheng YC
Mol Pharmacol; 1982 Mar; 21(2):478-82. PubMed ID: 7099148
[TBL] [Abstract][Full Text] [Related]
37. Antibody to dihydrofolate reductase from a methotrexate-resistant subline of the L1210 lymphoma.
Perkins JP; Hillman G; Fischer D; Bertino JR
Mol Pharmacol; 1969 May; 5(3):213-8. PubMed ID: 4389029
[No Abstract] [Full Text] [Related]
38. L1210 dihydrofolate reductase: activation and enhancement of methotrexate sensitivity.
Duffy TH; Sato JK; Vitols KS; Huennekens FM
Adv Enzyme Regul; 1985; 24():13-25. PubMed ID: 3835818
[TBL] [Abstract][Full Text] [Related]
39. CYTOGENETICS OF MOUSE LEUKEMIA L1210. I. ASSOCIATION OF A SPECIFIC CHROMOSOME WITH DIHYDROFOLATE REDUCTASE ACTIVITY IN AMETHOPTERIN-TREATED SUBLINES.
BIEDLER JL; ALBRECHT AM; HUTCHISON DJ
Cancer Res; 1965 Feb; 25():246-57. PubMed ID: 14264058
[No Abstract] [Full Text] [Related]
40. Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system.
Fry DW; Besserer JA; Boritzki TJ
Cancer Res; 1984 Aug; 44(8):3366-70. PubMed ID: 6547636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
